Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid [2]

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 676-677

  Hage, Chadi A ^a   Reynolds, John M ^b   Durkin, Michelle ^c   Wheat, L Joseph ^c   Knox, Kenneth S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METHODIST HOSPITAL   (United States)

^c Mira Vista Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN; GLUCONATE SODIUM; PIPERACILLIN PLUS TAZOBACTAM;

ACCURACY; ANALYTICAL ERROR; ASPERGILLUS FUMIGATUS; BRONCHOSCOPY; DIAGNOSTIC KIT; FALSE POSITIVE RESULT; FUNGAL CONTAMINATION; FUNGUS GROWTH; HUMAN; LETTER; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL;

ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; ELECTROLYTES; FALSE POSITIVE REACTIONS; HUMANS; MANNANS; PLASMA SUBSTITUTES;

ASPERGILLUS GALACTOMANNAN;

EID: 33847057250     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01940-06     Document Type: Letter

References (9)

1. Adam, O., A. Auperin, F. Wilquin, J. H. Bourhis, B. Gachot, and E. Chachaty. 2004. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin. Infect. Dis. 38:917-920.
2. Aubry, A., R. Porcher, J. Bottero, S. Touratier, T. Leblanc, B. Brethon, P. Rousselot, E. Raffoux, J. Menotti, F. Derouin, P. Ribaud, and A. Sulahian. 2006. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with β-lactam antibiotics in patients with hematological disorders. J. Clin. Microbiol. 44:389-394.
3. Hage, C. A., T. E. Davis, L. Egan, M. Parker, D. Fuller, A. M. Lemonte, M. Durkin, P. Connelly, L. J. Wheat, D. Blue-Hnidy, and K. S. Knox. 2007. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir. Med. 101:43-47.
4. Mattel, D., D. Rapezzi, N. Mordini, F. Cuda, C. Lo Nigro, M. Musso, A. Arnelli, S. Cagnassi, and A. Gallamini. 2004. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J. Clin. Microbiol. 42:5362-5363.
5. Musher, B., D. Fredricks, W. Leisenring, S. A. Balajee, C. Smith, and K. A. Marr. 2004. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42:5517-5522.
6. Pfeiffer, C. D., J. P. Fine, and N. Safdar. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42:1417-1427.
7. Stynen, D., J. Sarfati, A. Goris, M.-C. Prévost, M. Lesourd, H. Kamphuis, V. Darras, and J. P. Latgé. 1992. Rat monoclonal antibodies against Aspergillus galactomannan. Infect. Immun. 60:2237-2245.
8. Walsh, T. J., S. Shoham, R. Petraitiene, T. Sein, R. Schaufele, A. Kelaher, H. Murray, C. Mya-San, J. Bacher, and V. Petraitis. 2004. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J. Clin. Microbiol. 42:4744-4748.
9. Wheat, L. J. 2003. Rapid diagnosis of invasive aspergillosis by antigen detection. Transplant. Infect. Dis. 5:158-166.